The Key We Are Overlooking in Peripheral Vascular Disease

To change the prognosis of peripheral vascular disease patients, a referral for supervised exercise is paramount. This should be a cultural change, not only an individual recommendation.

ejercicio y enfermedad vascular periférica

A physically active lifestyle reduces the risk of cardiovascular events and functional impairment in patients with peripheral vascular disease.

The novelty of this work (forthcoming in Eur J Vasc Endovasc Surg) is that it compares physical activity patterns from peripheral vascular disease patients in two countries: one presenting an epidemic of sedentary and overweight individuals (United Stated) and another that actively promotes physical activity as a public health policy (the Netherlands).

Patients self-reported their physical activity following a binary classification (sedentarism or physical activity), with follow-up at 3, 6, and 12 months.

Participants were registered in the Patient-centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) registry, which included patients with new or worsening intermittent claudication.

This study included a total of 1098 patients: 743 recruited in the US (67.7%) and 355 in the Netherlands (32.3%).


Read also: What Is the Healthiest Diet?


American patients were older (mean age: 68.6 years vs. 65.3 years; p < 0.001) and heavier (41.3% vs. 20.5%; p < 0.001), but fewer were smokers (30.1% vs. 52.8%; p < 0.001) and more were female (41.3% vs. 31.4%; p = 0.002).

The main difference between countries was the patients’ supervised exercise baseline (1.6% in the US vs. 63.9% in the Netherlands; p < 0.001). Not only were Americans more sedentary at baseline, but also only a small percentage of them were formally instructed to exercise in a supervised manner.

Conclusion

To change the prognosis of symptomatic peripheral vascular disease patients, a referral for supervised exercise is paramount. Advising them to walk moreis not enough: a cultural change must take place.

Original Title: Physical Activity in Patients with Symptomatic Peripheral Artery Disease: Insights from the PORTRAIT Registry.

Reference: Poghni A. Peri-Okonny et al. Eur J Vasc Endovasc Surg. 2020 Jul 21;S1078-5884(20)30528-1. https://doi.org/10.1016/j.ejvs.2020.06.010.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

New Carotid PCI All-in-One System

Carotid stenting is equivalent to carotid endarterectomy in terms of major adverse events (death, AMI, and stroke). However, it entails higher risk of minor...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...